Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs

Journal of Pathology

Volumn 223, Issue 5, 2011, Pages 593-603

  Quattrocelli, Mattia ^a,b   Palazzolo, Giacomo ^a,d   Floris, Giuseppe ^c   Schöffski, Patrick ^c   Anastasia, Luigi ^d   Orlacchio, Aldo ^b   Vandendriessche, Thierry ^a,e   Chuah, Marinee K L ^a,e   Cossu, Giulio ^f   Verfaillie, Catherine ^a   Sampaolesi, Maurilio ^a,g  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g UNIVERSITY OF PAVIA   (Italy)

Author keywords

CD56; Epigenetic memory; iPSCs; Muscular dystrophy; Pericytes

Indexed keywords

ALPHA SARCOGLYCAN; CD56 ANTIGEN; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL MANIPULATION; CELL SELECTION; CHIMERA; CONTROLLED STUDY; EPIGENETICS; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MEMORY CELL; MESOANGIOBLAST; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MUSCLE TISSUE; MUSCULAR DYSTROPHY; NEWBORN; NONHUMAN; PERICYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; STEM CELL; TERATOMA; TISSUE SPECIFICITY;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD56; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA TRANSPOSABLE ELEMENTS; EPIGENESIS, GENETIC; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PERICYTES; REGENERATION; SARCOGLYCANS; TRANSFECTION;

EID: 79952560256     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2845     Document Type: Article

References (30)

1. Emery AE. The muscular dystrophies. Lancet 2002; 359: 687-695. (Pubitemid 34203773)
2. Cossu G, Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol Med 2007; 13: 520-526. (Pubitemid 350130348)
3. Duclos F, Straub V, Moore SA, et al. Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J Cell Biol 1998; 142: 1461-1471. (Pubitemid 28452596)
4. Quattrocelli M, Cassano M, Crippa S, et al. Cell therapy strategies and improvements for muscular dystrophy. Cell Death Differ 2010; 17: 1222-1229.
5. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961; 9: 493-495.
6. Montarras D, Morgan J, Collins C, et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005; 309: 2064-2067. (Pubitemid 41362326)
7. Cossu G, Biressi S. Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin Cell Dev Biol 2005; 16: 623-631. (Pubitemid 41247885)
8. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of α-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003; 301: 487-492. (Pubitemid 36900300)
9. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313.
10. Sampaolesi M, Blot S, D'Antona G, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006; 444: 574-579. (Pubitemid 44864430)
11. Dellavalle A, Sampaolesi M, Tonlorenzi R, et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007; 9: 255-267. (Pubitemid 46349927)
12. Tonlorenzi R, Dellavalle A, Schnapp E, et al. Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. Curr Protoc Stem Cell Biol 2007; 2: 2B 1.
13. Graf T, Enver T. Forcing cells to change lineages. Nature 2009; 462: 587-594.
14. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676. (Pubitemid 44233629)
15. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-886.
16. Darabi R, Gehlbach K, Bachoo RM, et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 2008; 14: 134-143. (Pubitemid 351214552)
17. Mizuno Y, Chang H, Umeda K, et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 2010; 24: 2245-2253.
18. + hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 2009; 114: 1319-1330.
19. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008; 132: 567-582. (Pubitemid 351253686)
20. Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-290.
21. Polo JM, Liu S, Figueroa ME, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010; 48: 848-855.
22. Jaenisch R. Stem cells, pluripotency and nuclear reprogramming. J Thromb Haemost 2009; 7(suppl 1): 21-23.
23. Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 120: 51-59.
24. Peault B, Rudnicki M, Torrente Y, et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007; 15: 867-877. (Pubitemid 46621645)
25. Buckingham M. Skeletal muscle progenitor cells and the role of Pax genes. C R Biol 2007; 330: 530-533. (Pubitemid 47040689)
26. Collins CA, Gnocchi VF, White RB, et al. Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation. PLoS One 2009; 4: e4475.
27. Welstead GG, Schorderet P, Boyer LA. The reprogramming language of pluripotency. Curr Opin Genet Dev 2008; 18: 123-129. (Pubitemid 351749825)
28. Eminli S, Foudi A, Stadtfeld M, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009; 41: 968-976.
29. Stadtfeld M, Apostolou E, Akutsu H, et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010; 465: 175-181.
30. Hoffman EP, Morgan JE, Watkins SC, et al. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci 1990; 99: 9-25. (Pubitemid 20324762)